Ken Griffin Nephros Inc Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nephros Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 14,289 shares of NEPH stock, worth $21,862. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,289
Previous 17,236
17.1%
Holding current value
$21,862
Previous $29,000
27.59%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.29MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.51 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$309,0500.0% of portfolio
-
Bard Associates Inc Chicago, IL155KShares$237,5640.09% of portfolio
-
Geode Capital Management, LLC Boston, MA84.9KShares$129,8200.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL55.7KShares$85,2360.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $15.8M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...